21 September 2023
Canadian Agency for Drugs and Technologies in Health
Flag this item
Health, C., 2023. CADTH Reimbursement Review Rivaroxaban Nonsponsored Therapeutic area: Venous thromboembolic events, Canadian Agency for Drugs and Technologies in Health.
Retrieved from https://policycommons.net/artifacts/4850260/cadth-reimbursement-review-rivaroxaban-nonsponsored-therapeutic-area/5687102/ on 09 Dec 2023. CID: 20.500.12592/qtfjbn.
Download citation (RIS)